Concepedia

Idit Sagiv-Barfi

IS

Statistics

Publications

17

Citations

2.6K

H-Index

14

Active since

2009

Affiliations

Stanford University(Current)

Stanford Medicine

Centre de Recherche en Cancérologie de Lyon

Howard Hughes Medical Institute

Hebrew University of Jerusalem

Idit Sagiv-Barfi is an author at Stanford University specializing in cancer immunology, cancer immunotherapy, and immunology.

ORCID

Publications per year

2009–2022

17

Publications

17

Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK

Idit Sagiv-Barfi, Holbrook E. Kohrt, Debra K. Czerwinski et al. · Proceedings of the National Academy of Sciences · 2015 · 446 citations · Full text

, , +17

Depleting tumor-specific Tregs at a single site eradicates disseminated tumors

Aurélien Marabelle, Holbrook E. Kohrt, Idit Sagiv-Barfi et al. · Journal of Clinical Investigation · 2013 · 405 citations · Full text

, , +17

Eradication of spontaneous malignancy by local immunotherapy

Idit Sagiv-Barfi, Debra K. Czerwinski, Shoshana Levy et al. · Science Translational Medicine · 2018 · 361 citations

, , +16

Depleting tumor-specific Tregs at a single site eradicates disseminated tumors

Aurélien Marabelle, Holbrook E. Kohrt, Idit Sagiv-Barfi et al. · Journal of Clinical Investigation · 2013 · 309 citations · Full text

, , +17

Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies

Holbrook E. Kohrt, Ariane Thielens, Aurélien Marabelle et al. · Blood · 2013 · 275 citations

, , +17

1–5 of 17